Medicine

Grants

Grants per year 1991 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2034

• 1305 Active
• 5997 Finished

Grants per year

Search results

• Active

  Prot #REC-4881-221: A Phase 2, Open Label Study of REC-4881 in Participants with Unresectable Locally Advanced or Metastatic Cancer with AXIN1 or APC Mutation

  Kalyan, A. (PD/PI)

  PPD Investigator Services, LLC, Recursion Pharmaceuticals, Inc.

  5/6/24 → 5/6/27

  Project: Research project

• Prot #GMS-PH-001: PHINDER: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection

  Bemiss, B. (PD/PI)

  Medpace, Inc., United Therapeutics Corporation

  5/2/24 → 5/2/27

  Project: Research project

• Prot #CT7001_003 (SUMIT-ELA): A Phase 1b/2 Open-Label Study of Samuraciclib in Combination with Elacestrant in Participants with Metastatic or Locally Advanced Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

  Gradishar, W. J. (PD/PI)

  Fortrea, Inc., Carrick Therapeutics Ltd

  5/2/24 → 5/2/27

  Project: Research project

• HARC: HIV accessory and regulatory complexes

  Hultquist, J. F. (PD/PI)

  University of California, San Francisco, National Institute of Allergy and Infectious Diseases

  5/1/24 → 4/30/25

  Project: Research project

• Absolute Neutrophil Count (ANC) by Duffy Status Project

  Godley, L. A. (PD/PI) & Ji, P. (PD/PI)

  American Society of Hematology

  5/1/24 → 4/30/25

  Project: Research project

• STING signaling in T cells regulation of intestinal homeostasis and inflammatorybowel diseases

  Cong, Y. (PD/PI), Cong, Y. (PD/PI), Yang, W. (Other), Yang, W. (Other), Yao, S. (Other), Yao, S. (Other), Yu, T. (Other) & Yu, T. (Other)

  National Institute of Diabetes and Digestive and Kidney Diseases

  5/1/24 → 4/30/26

  Project: Research project

• Cardiac Imaging of Neuro-Embolic Mechanisms in Atriopathies causing Stroke (CINEMAS) - CR

  Markl, M. (PD/PI), Bernstein, R. A. (Co-Investigator) & Lee, D. C. (Co-Investigator)

  University of Miami, National Heart, Lung, and Blood Institute

  5/1/24 → 4/30/29

  Project: Research project

• Prot #STU00222155: Rapid Onsite Cytopathologic Evaluation for Improved Molecular Marker Testing via Endobronchial Ultrasound Bronchoscopy - A Randomized Controlled Trial

  Kapp, C. M. (PD/PI) & Wahidi, M. M. (Co-Investigator)

  Johns Hopkins University, AstraZeneca Pharmaceuticals LP

  5/1/24 → 4/30/26

  Project: Research project

• Prot #POLARIS2022-001: ADI-PEG 20 or Placebo Plus Gemcitabine and Docetaxel in Previously Treated Subjects with Leiomyosarcoma (ARGSARC): A Randomized, Double-Blind, Multi-Center Phase 3 Trial

  Pollack, S. M. (PD/PI)

  Polaris Pharmaceuticals, Inc.

  4/30/24 → 4/30/27

  Project: Research project

• Co-Design and Testing of a Patient-Facing Approach to Reduce Barriers to Primary Care for People with Spinal Cord Injuries

  Haywood, C. (PD/PI), Haywood, C. (PD/PI), Berry, A. B. (Co-Investigator), Berry, A. B. (Co-Investigator), Lagu, T. (Co-Investigator) & Lagu, T. (Co-Investigator)

  Craig H. Neilsen Foundation

  4/30/24 → 4/29/26

  Project: Research project

• Specialty versus Oncology Delivered Palliative Care for Patients with Acute Myeloid Leukemia

  Neagle, J. T. (PD/PI)

  Massachusetts General Hospital, Patient-Centered Outcomes Research Institute

  4/29/24 → 1/1/30

  Project: Research project

• Prot #BTCRC-LYM20-463: A Single Arm Phase I/II Study of Tazemetostat with Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma

  Karmali, R. (PD/PI)

  Hoosier Cancer Research Network, Inc., Epizyme, Inc.

  4/26/24 → 4/26/27

  Project: Research project

• Prot #GO44479: A Phase II, Open-label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients with Resected Pancreatic Ductal Adenocarcinoma

  Mulcahy, M. F. (PD/PI)

  Fortrea, Inc., Genentech, Inc

  4/26/24 → 7/1/29

  Project: Research project

• Prot #EFC17757: A Randomized, Double-Blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination with Corticosteroids Versus Placebo in Combination with Corticosteroids in Participants at Least 12 Years of Age with Newl

  Moreira, J. (PD/PI)

  ICON Clinical Research, LLC, Sanofi US Services Inc.

  4/26/24 → 4/26/27

  Project: Research project

• Prot #CP-MVC-101-01: A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of TAK-186 (also known as MVC-101), An EGFR x CD3 COnditional Bispecific Redirected Activation (COBRA) Protein in Patients with Unresectable Locally Advanced or Metastatic

  Mahalingam, D. (PD/PI)

  PPD Investigator Services, LLC, Takeda Development Center Americas, Inc.

  4/22/24 → 4/22/27

  Project: Research project

• Prot #C1763102: A Phase 1b Study of Oral AS-1763 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

  Ma, S. (PD/PI)

  Worldwide Clinical Trials, Inc., Carna Biosciences, Inc.

  4/19/24 → 4/19/27

  Project: Research project

• Prot #STU00220711: Validation of an Automated System for Transthoracic echocardiographic analysis (VAST Multi-rater Study)

  Cremer, P. C. (PD/PI)

  UAB Ligence

  4/16/24 → 4/15/25

  Project: Research project

• Prot #ITL-2001-CL-301: MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

  Shah, S. J. (PD/PI)

  Medpace Clinical Research LLC, Intellia Therapeutics, Inc.

  4/16/24 → 4/16/27

  Project: Research project

• Mosaic Loss of the Y Chromosome in Cardiac Amyloidosis

  Jin, J. (PD/PI) & Liu, P. (Other)

  University of Virginia, National Institute on Aging

  4/15/24 → 1/31/29

  Project: Research project

• Prot #2138-CL-0101: A Phase 1/1b Study of ASP2138 in Participants with Metastatic or Locally Advanced Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma Whose Tumors Have Claudin (CLDN) 18.2 Exp

  Mahalingam, D. (PD/PI)

  ICON Clinical Research, LLC, Astellas Pharma Global Development, Inc.

  4/15/24 → 4/15/27

  Project: Research project

• Determination of thd Efficacy of HistaQuel to Inhibit Mast Cell Responses In Vivo

  O'Sullivan, J. A. (PD/PI)

  Researched Nutritionals, LLC

  4/15/24 → 4/14/25

  Project: Research project

• Prot #CYTB323K12201: A Phase II, Multi-Part, Three-Year, Randomized, Open-Label, Assessor-Blinded, Active-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Rituximab Treatment in Participants with Severe R

  Georges, G. E. (PD/PI)

  Novartis Pharmaceuticals Corporation

  4/10/24 → 3/31/30

  Project: Research project

• Prot #R5459-RT-1956: A Noninterventional Extension Study for Patients Treated in Study R5459-RT-1944 with REGN5459 or REGN5458 (BCMA x CD3 Bispecific Antibodies) Who Receive a Kidney Transplant

  Friedewald, J. J. (PD/PI)

  Parexel, Regeneron Pharmaceuticals, Inc.

  4/10/24 → 4/10/27

  Project: Research project

• Prot #SC291-101: A Phase 1 Study Evaluating SC291, a Hypoimmune Allogeneic CD19-Directed CAR T Cell Therapy, in Relapsed and/or Refractory B-Cell Malignancies (ARDENT)

  Karmali, R. (PD/PI)

  PPD Development, Sana Biotechnology, Inc.

  4/9/24 → 4/9/27

  Project: Research project

• Prot #ZN-c3-004: A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma

  Matei, D. E. (PD/PI)

  Gynecologic Oncology Group, K-Group Beta, Inc.

  4/8/24 → 4/8/27

  Project: Research project